• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    WITHDRAWN: FDA accelerated approval to infigratinib for metastatic cholangiocarcinoma

    FDA

    LianBio inks $325M IPO for pipeline with BMS, BridgeBio, Lyra

    FIERCEBIOTECH

    BridgeBio grabs a second priority review for the portfolio — giving Perceptive

    ENDPTS

    BridgeBio Pharma & Affiliate QED Announce FDA Acceptance NDA for Infigratinib

    GLOBENEWSWIRE

    Ivy Brain Tumor Center and BridgeBio Pharma’s QED Announce Dosing

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.